Skip to main content

Skinvive by Juvederm FDA Approval History

FDA Approved: Yes (First approved May 15, 2023)
Brand name: Skinvive by Juvederm
Generic name: hyaluronic acid and lidocaine
Dosage form: Injectable Gel
Company: AbbVie Inc.
Treatment for: Facial Wrinkles

Last updated by Judith Stewart, BPharm on May 30, 2023.

Skinvive by Juvéderm (hyaluronic acid and lidocaine) is an intradermal microdroplet injection containing a dermal filler and a local anesthetic used to improve skin smoothness of the cheeks in adults over the age of 21.

 

Development timeline for Skinvive by Juvederm

DateArticle
May 15, 2023Approval FDA Approves Skinvive by Juvéderm (hyaluronic acid) Microdroplet Injection to Improve Skin Smoothness of the Cheeks

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.